Colonial Trust Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Colonial Trust Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-177	Closed	-$16.8K	–	1031
2024 Q1	$16.8K	Buy	+177	New	+$16.4K	﹤0.01%	506
2022 Q1	–	Sell	-6,024	Closed	-$674K	–	189
2021 Q4	$674K	Sell	6,024 -730	-11%	-$88K	0.08%	124
2021 Q3	$849K	Sell	6,754 -355	-5%	-$45.7K	0.1%	112
2021 Q2	$963K	Buy	7,109 +1,465	+26%	+$193K	0.12%	111
2021 Q1	$766K	Buy	5,644 +1,535	+37%	+$230K	0.1%	118
2020 Q4	$578K	Buy	4,109 +1,125	+38%	+$144K	0.08%	121
2020 Q3	$333K	Buy	2,984 +761	+34%	+$85.3K	0.05%	136
2020 Q2	$249K	Buy	+2,223	New	+$219K	0.04%	141

Other funds holding XBI

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Colonial Trust Advisors's XBI Position: Q2 2024 in Review

Colonial Trust Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 177 shares — an estimated $16.8K sold.

Colonial Trust Advisors first reported a position in XBI in Q2 2020 and held it in 8 quarters. The position peaked at $963K in Q2 2021. 762 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Colonial Trust Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Colonial Trust Advisors sold 177 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $16.8K.
Colonial Trust Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 8 quarters.
Colonial Trust Advisors's State Street SPDR S&P Biotech ETF position peaked at $963K in Q2 2021.
762 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Colonial Trust Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.